# Determining Optimal Continuation Treatment Duration for Depressed Children and Adolescents

> **NCT00332787** · NA · COMPLETED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 200 (—)

## Conditions studied

- Depression

## Interventions

- **DRUG:** Fluoxetine

## Key facts

- **NCT ID:** NCT00332787
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-06
- **Primary completion:** —
- **Final completion:** 2005-10
- **Target enrollment:** 200 (—)
- **Last updated:** 2014-01-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00332787

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00332787, "Determining Optimal Continuation Treatment Duration for Depressed Children and Adolescents". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00332787. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*